ANAB - アナプティスバイオ (AnaptysBio Inc.) アナプティスバイオ

 ANABのチャート


 ANABの企業情報

symbol ANAB
会社名 AnaptysBio Inc (アナプティスバイオ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アナティスバイオ(AnaptysBio Inc.)は米国の生物技術会社である。同社は炎症および免疫腫瘍学における満たされていない医療ニーズに焦点を当てた抗体製品候補の開発に従事する。同社は、抗体産生の自然過程をインビトロで複製するように設計された抗体発見技術プラットフォームを使用して、その製品候補を開発する。その製品パイプラインには、未治療の医療ニーズを伴う重度の炎症性障害を治療するために開発されているANB020とANB019が含まれる。ANB020製品候補は、インターロイキン-33の活性を阻害する抗体であり、重度の成人喘息および重度の成人のピーナッツアレルギーの治療に使用される。同社は、一般化した膿疱性乾癬(GPP)および掌蹠膿疱性乾癬(PPP)と呼ばれる稀な炎症性疾患の治療のために、インターロイキン36受容体を阻害する抗体ANB019製品候補の開発に従事する。   アナプティスバイオは米国のバイオ医薬品企業。臨床段階で、炎症の治療に関連する抗体医薬品の開発に従事。同社は体細胞超変異を用いる抗原結合物質を生成するプラットフォ―ムを開発、試験管内で抗体生成のプロセスを再現する。医療ニ―ズはあるが治療法がまだない炎症の分野に専念する。本社所在地はカリフォルニア州サンディエゴ。   
本社所在地 10421 Pacific Center Court Suite 200 San Diego CA 92121 USA
代表者氏名 Hamza Suria ハムザスリア
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 858-362-6295
設立年月日 38657
市場名 NASDAQ National Market System
ipoyear 2017年
従業員数 60人
url www.anaptysbio.com
nasdaq_url https://www.nasdaq.com/symbol/anab
adr_tso
EBITDA EBITDA(百万ドル) -46.19900
終値(lastsale) 90.395
時価総額(marketcap) 2172774988.145
時価総額 時価総額(百万ドル) 2284.503
売上高 売上高(百万ドル) 3.00000
企業価値(EV) 企業価値(EV)(百万ドル) 228.214
当期純利益 当期純利益(百万ドル) -37.06000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 AnaptysBio Inc revenues decreased from $7M to $0K. Net loss increased from $14.1M to $28.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development - Balancing increase of 45% to $20.7M (expense) General and administrative - Balancing increase of 60% to $4.6M (expense).

 ANABのテクニカル分析


 ANABのニュース

   McAfee, GameStop rise; AnaptysBio, Soleno fall  2021/03/08 21:18:59 ABC News
Stocks that traded heavily or had substantial price changes Monday: McAfee, GameStop rise; AnaptysBio, Soleno fall
   Antibody Library Technology Market (2021 to 2027) – Drivers, Challenges and Trends – AnaptysBio Inc, MorphoSys AG, XOMA Corporation, Abzena Plc, AvantGen Inc  2021/03/05 03:20:17 OpenPR
The Global Antibody Library Technology Market survey report gives a detailed forecast and prospects of the market where 2020 is set as the base year and the forecast period is until 2027. It covers several factors that underline the market
   AnaptysBio Factors Likely to Have Influenced Earnings Results Stock market Insights & financial analysis  2021/03/01 17:40:00 Stock Market Daily
AnaptysBio announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed  2021/02/12 13:10:51 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12) 4D Molecular Therapeutics Inc (NASDAQ: FDMT ) Adagene Inc (NASDAQ: ADAG ) (went public Tuesday) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) AnaptysBio Inc (NASDAQ: ANAB ) (received a double upgrade from JPMorgan) AngioDynamics, Inc. (NASDAQ: ANGO ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) argenx SE – ADR (NASDAQ: ARGX ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Bausch Health Companies Inc (NYSE: BHC ) Bolt Biotherapeutics Inc (NASDAQ: BOLT ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cara Therapeutics Inc (NASDAQ: CARA ) Celcuity Inc (NASDAQ: CELC ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) DermTech Inc (NASDAQ: DMTK ) ( announced award of contract for coverage of its skin cancer gene expression test) ESSA Pharma Inc (NASDAQ: EPIX ) (reacted to first-quarter results) Evogene Ltd (NASDAQ: EVGN ) FibroGen Inc (NASDAQ: FGEN ) G1 Therapeutics Inc (NASDAQ: GTHX ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) GenMark Diagnostics, Inc (NASDAQ: GNMK ) (moved on M&A speculation) Guardant Health Inc (NASDAQ: GH ) Guardion Health Sciences Inc (NASDAQ: GHSI ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunome Inc (NASDAQ: IMNM ) Infinity Pharmaceuticals Inc.
   Why ESSA Pharma, AnaptysBio And More Are Moving Today  2021/02/11 17:46:33 Benzinga
ESSA Pharma Inc. (NASDAQ: EPIX ) shares are trading higher after … Full story available on Benzinga.com
   McAfee, GameStop rise; AnaptysBio, Soleno fall  2021/03/08 21:18:59 ABC News
Stocks that traded heavily or had substantial price changes Monday: McAfee, GameStop rise; AnaptysBio, Soleno fall
   Antibody Library Technology Market (2021 to 2027) – Drivers, Challenges and Trends – AnaptysBio Inc, MorphoSys AG, XOMA Corporation, Abzena Plc, AvantGen Inc  2021/03/05 03:20:17 OpenPR
The Global Antibody Library Technology Market survey report gives a detailed forecast and prospects of the market where 2020 is set as the base year and the forecast period is until 2027. It covers several factors that underline the market
   AnaptysBio Factors Likely to Have Influenced Earnings Results Stock market Insights & financial analysis  2021/03/01 17:40:00 Stock Market Daily
AnaptysBio announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed  2021/02/12 13:10:51 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12) 4D Molecular Therapeutics Inc (NASDAQ: FDMT ) Adagene Inc (NASDAQ: ADAG ) (went public Tuesday) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) AnaptysBio Inc (NASDAQ: ANAB ) (received a double upgrade from JPMorgan) AngioDynamics, Inc. (NASDAQ: ANGO ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) argenx SE – ADR (NASDAQ: ARGX ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Bausch Health Companies Inc (NYSE: BHC ) Bolt Biotherapeutics Inc (NASDAQ: BOLT ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cara Therapeutics Inc (NASDAQ: CARA ) Celcuity Inc (NASDAQ: CELC ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) DermTech Inc (NASDAQ: DMTK ) ( announced award of contract for coverage of its skin cancer gene expression test) ESSA Pharma Inc (NASDAQ: EPIX ) (reacted to first-quarter results) Evogene Ltd (NASDAQ: EVGN ) FibroGen Inc (NASDAQ: FGEN ) G1 Therapeutics Inc (NASDAQ: GTHX ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) GenMark Diagnostics, Inc (NASDAQ: GNMK ) (moved on M&A speculation) Guardant Health Inc (NASDAQ: GH ) Guardion Health Sciences Inc (NASDAQ: GHSI ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunome Inc (NASDAQ: IMNM ) Infinity Pharmaceuticals Inc.
   Why ESSA Pharma, AnaptysBio And More Are Moving Today  2021/02/11 17:46:33 Benzinga
ESSA Pharma Inc. (NASDAQ: EPIX ) shares are trading higher after … Full story available on Benzinga.com
   Allscripts Healthcare, Concho Resources: 5 Top Stock Gainers for Wednesday  2020/10/14 17:16:42 The Street
Allscripts, AnaptysBio, Concho Resources, Voxx International and Nio are five top stock gainers for Wednesday.
   Benzinga's Top Upgrades, Downgrades For October 14, 2020  2020/10/14 10:01:00 Benzinga
Upgrades For AnaptysBio Inc (NASDAQ: ANAB), Guggenheim upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, AnaptysBio …
   AnaptysBio Announces Second Quarter 2020 Financial Results and Provides Pipeline Updates  2020/08/10 12:05:00 GlobeNewswire
Interim 8-Week Top-Line Data From Etokimab ECLIPSE Phase 2 Trial in Chronic Rhinosinusitis with Nasal Polyps Did Not Demonstrate Statistical Significance…
   ANAPTYSBIO 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against AnaptysBio, Inc. - ANAB  2020/05/26 02:50:00 PR Newswire
NEW ORLEANS, May 25, 2020 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until May 26, 2020 to file lead plaintiff applications in a securities class action lawsuit…
   Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?  2020/05/25 15:30:10 Zacks Investment Research
Is (ANAB) Outperforming Other Medical Stocks This Year?

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アナプティスバイオ ANAB AnaptysBio Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)